All Activity

A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Situs Dominoqq A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Situs Taruhan Bola A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Slot Online Terpercaya A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Bolagila Resmi A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Situs Livecasino Online A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Agen Sbobet

The Massachusetts House of Representatives has voted to create a five-year pilot program allowing the use of psychedelics to treat mental health conditions. Under the proposal, which is part of a $561 million bond bill that was approved by a vote of 148-2 on Wednesday, “clinically appropriate patients” could use “naturally occurring psychedelic materials” for “on-site administration by a multi-disciplinary care team in a supervised licensed mental health clinic setting.” Under the legislation, there would be a new Medical Psychedelics Fund, and the Department of Public Health would issue up to three permits to mental health clinics to participate in the program “for the purposes of establishing the best and safest clinical practices for psychedelic mental health treatment programs” and for the purposes of “collecting patient outcomes data regarding the benefits of psychedelic pharmacotherapy.” Participating clinics could not be “subsidiaries, affiliates or members of cannabis industry organizations, psychedelic molecule development companies or pharmaceutical companies,” it says, and they would need to “track patient care outcomes data related to the identification, diagnosis and psychedelic treatment of depression, anxiety, post-traumatic stress disorder and substance use disorder.” The measure specifies that current state drug criminalization laws “shall not apply to the medical use of psilocybin and psilocin as provided under the pilot program.” With respect to other psychedelics, the legislation says that state health officials will “coordinate with research institutions, as it deems appropriate, to facilitate, expand and expedite federally-authorized research on psychedelic-assisted therapies, including, but not limited to, psilocybin, ibogaine, 5-methoxy-n,n-dimethyltryptamine, and 3,4-methylenedioxymethamphetamine, in the commonwealth, including efforts to pursue federal approvals and available state and federal funding in compliance with applicable federal regulations.” The department would be charged with issuing regulations to oversee the effort, including on the “process of storing, dispensing and administrating psychedelics.” “The department shall establish by regulation all standards and requirements governing the production and cultivation of naturally occurring psychedelic materials necessary for the pilot program, including, but not limited to, producer licensing and operations,” the bill says. The psychedelics reform was championed by Rep. Marjorie Decker (D) and was folded into a larger amendment that was adopted to the bill in a unanimous vote. The House-passed economic development bill next heads to the Senate and then, potentially, to the desk of Gov. Maura Healey (D). — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — “It’s pretty mind-blowing to see that psychedelics offer, under the right medical guidance, real treatment, and I want to be bold to say it cures,” Decker told The Boston Globe. “It’s not a lifetime of treatment. It’s a cure.” “It’s great to see that there’s an alignment in which the federal government and state government is moving in the same direction of trying to make people’s lives better,” she said, referring to a psychedelics executive order President Donald Trump signed in April. “But we certainly have not been a state…that has been waiting for the winds of change at the federal level to decide how to take care of people in our state.” The passage of the psychedelics legislation comes after Massachusetts voters in 2024 defeated a ballot measure that would have broadly legalized psychedelics, allowing adults 21 and older to legally possess, grow and share certain amounts of substances such as psilocybin, ibogaine and DMT. Advocates praised the new legislative development. “This is a triumph for a new kind of politics in the psychedelics movement, built on integrity, compromise and mutual, earned trust among grassroots advocates, lawmakers, scientific researchers, national organizations and philanthropists,” Graham Moore, educational outreach director for Mass Healing, said in a press release. “At the beginning of this legislative session, the psychedelic movement was operating with a trust deficit in Massachusetts because of catastrophic mismanagement. This victory was possible only through responsible leadership: unafraid to confront bad actors, admit mistakes, and operate dynamically.” Jamie Morey, the group’s executive director, said that the group was “born from the ashes of the failed 2024 psychedelic ballot question and fueled by my passion as a mother on a mission to keep fighting for legal access to psychedelic healing for my own family and others across Massachusetts. “The House’s passage of this bill is a victory for everyone affected by PTSD, treatment-resistant depression, addiction and other serious mental and physical health conditions who urgently need new treatment options,” she said. During the current legislative session, various pieces of psychedelics legislation have been filed, with some clearing committees. The Massachusetts Psychiatric Society endorsed several of the psychedelics reform bills, including one to decriminalize psilocybin possession. In 2024, the governor signed a military veterans-focused bill that includes provisions to create a psychedelics working group to study and make recommendations about the potential therapeutic benefits of substances like psilocybin and MDMA. Meanwhile in Massachusetts, state officials have formally certified that an initiative to roll back that state’s marijuana legalization law will appear on the November ballot. The anti-cannabis campaign, however, is facing a new challenge to some of its most recently submitted signatures. The post Massachusetts Lawmakers Pass Bill To Legalize Psychedelic Therapy With New Pilot Program appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A congressional committee has advanced legislation that would require the Department of Health and Human Services (HHS) to study how prevalent drug testing for marijuana, fentanyl and other drugs is in hospital emergency departments. The House Energy and Commerce Subcommittee on Health last month approved the legislation from Rep. Ted Lieu (D-CA), known as “Tyler’s Law,” after Tyler Shamash, a 19-year-old who died following a fentanyl ingestion in 2018 and was not tested for the drug when brought to the hospital for a suspected overdose. While the legislation, H.R. 2004, is largely focused on fentanyl, it says that within a year of passage the HHS secretary would need to complete a study to determine “how frequently hospital emergency departments test for fentanyl (in addition to testing for other substances such as amphetamines, phencyclidine, cocaine, opiates, and marijuana) when a patient is experiencing an overdose.” The study would also need to look at costs associated with fentanyl testing, the potential benefits and risks of such testing and how it may impact patients’ experiences—including with respect to confidentiality and privacy protections and the patient-physician relationship. The bill, which has 60 House cosponsors, says that within six months of completing the study, HHS would also need to issue guidance covering: “(1) Whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose. (2) How hospitals can ensure that clinicians in their hospital emergency departments are aware of which substances are being tested for in their routinely-administered drug tests, regardless of whether those tests screen for fentanyl. (3) How the administration of fentanyl testing in hospital emergency departments may affect the future risk of overdose and general health outcomes.” The House committee approved the bill without amendment in a voice vote. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Companion legislation in the Senate from Sen. Jim Banks (R-IN) was approved by the Health, Education, Labor, and Pensions Committee in January—but not before being amended to remove the language that references marijuana and other drugs besides fentanyl. Unlike the House bill, the HHS secretary would have three years to complete the study on hospital drug testing under the amended Senate proposal. In April, a pair of Republican senators filed a separate bill that would require the federal government to track the cost of hospitalization due to marijuana use. The Marijuana Impact on Medicaid Act of 2026 from Sens. Ted Budd (R-NC) and Pete Ricketts (R-NE) would require the secretary of the Department of Health and Human Services (HHS) to compile data on “Federal and State expenditures under the Medicaid program…that are attributable to costs incurred for providing medical assistance for inpatient hospital services, outpatient hospital services, and for services received at a hospital emergency room…related to marijuana use.” The bill’s language is similar to two amendments Budd previously filed on the cannabis and hospitalization issue that didn’t end up being considered on the Senate floor. The post Bill To Require Federal Health Officials To Track Testing For Marijuana And Other Drugs In Hospital ERs Advances In Congress appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The web is actually bogged lower along with phony weblogs without any actual information however the publish had been wonderful as well as really worth the actual study. Thanks with regard to discussing this particular beside me. sbobet

GOP congressman: Marijuana makes you a “loser in life”; MA anti-cannabis measure faces challenge; Study: Medical marijuana for restless legs syndrome Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Former Acting Homeland Security Secretary Chad Wolf sent a letter urging Congress not to reverse the scheduled recriminalization of hemp THC products, saying it would “embolden foreign criminal actors” linked to China and would “undermine public health.” Rep. Pete Sessions (R-TX) claimed that marijuana “hurts your DNA,” will “make you a loser in life” and leads to young women being “taken advantage of.” “There is not one positive effect of this marijuana.” The Massachusetts State Ballot Law Commission is considering a new challenge to signatures for an initiative to roll back the state’s marijuana legalization law that other state officials certified to appear on the November ballot this week. A study found that medical cannabis is “effective” in reducing the severity of restless legs syndrome. “Improvements were observed after 1 and 3 months of treatment and were maintained after 1 year among patients who continued therapy.” A federal judge on the U.S. Court of Appeals for the Fourth Circuit issued a concurring opinion in a gun case saying that the presumed link between cannabis and firearms “can no longer hold water in this era of widespread marijuana legalization.” Minnesota Psychedelic Medicine Task Force Chair Jessica Nielson describes in a new op-ed how the state is on the verge of making psilocybin therapy available to patients who need it. “The question of whether to create a psilocybin therapeutic access program is not about if, but how it will be implemented.” / FEDERAL Sen. John Fetterman (D-PA) discussed his support for legalizing marijuana and psychedelics. / STATES New Jersey Gov. Mikie Sherrill (D) signed budget legislation that allocates about $82 million in marijuana revenue to various programs. Kansas Republican gubernatorial candidates agreed on opposing marijuana legalization during a debate. Virginia current and former lawmakers continued to clash over accusations that budget legislation with provisions to legalize recreational marijuana sales inadvertently removed all cannabis penalties for a period of a year—though commonwealth’s attorneys who had initially expressed concerns about the issue say that actions taken by the Code Commission solved the problem. Ohio lawmakers are considering legislation to allow single-license marijuana processors to apply for cultivator and dispensary permits. Maryland regulators launched an initiative to connect social equity cannabis businesses with certified minority-owned suppliers. Massachusetts regulators approved a stipulated agreement with a marijuana business over alleged violations. Colorado marijuana regulators published a new dashboard that tracks open records requests. New York’s health commissioner spoke on a panel about recent trends in emergency department visits related to cannabis use. The Georgia Access to Medical Cannabis Commission will meet on Wednesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Osseo, Minnesota hosted a town hall meeting about plans to open a municipal-owned marijuana dispensary. / INTERNATIONAL Gandaki, Nepal lawmakers approved a bill to legalize cannabis cultivation for medical and industrial use. Victoria, British Columbia, Canada’s mayor sent a letter to provincial officials in support of a cannabis club. / SCIENCE & HEALTH A study found that “cannabidiol alleviates traumatic brain injury-induced neuronal damage and cognitive deficits.” A study of rats highlighted the “preventive effects of CBD- and THC-containing [cannabis oil] against early liver alterations associated with” metabolic dysfunction-associated steatotic liver disease. / ADVOCACY, OPINION & ANALYSIS The Wall Street Journal editorial board noted California’s ongoing struggles to combat the illicit cannabis market under legalization. The Niskasen Center published a report with recommendations on “building and fixing adult-use cannabis markets.” / BUSINESS Curaleaf Holdings, Inc. announced that exchange-traded options on its subordinate voting shares will commence trading on the Montréal Exchange on Monday. Trulieve Cannabis Corp. was included on TIME’s list of America’s Best Companies 2026. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Former Trump official pushes hemp THC ban (Newsletter: July 13, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Yes, I am entirely agreed with this article, and I just want say that this article is very helpful and enlightening. I also have some precious piece of concerned info !!!!!!Thanks. situs slot resmi

This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… วิธีแทงบอลสเต็ปสำหรับมือใหม่

Wow i can say that this is another great article as expected of this blog.Bookmarked this site.. kokitoto daftar

Thank you for very usefull information.. game premium oma55

The best horror survival game ever made is FNAF; how about we play it? Discover the terrifying Five Nights at Freddy's with its unsettling shifts and face-moving animatronics right now!

You can drift in Drift Boss for a long time, and the game tests your speed and ability to drive through difficult tracks. Everyone can enjoy the game. You can try to beat your high score, get coins, or open up new cars. There is something new to learn every time you play.

If you want to dive into a brilliant galaxy of quick actions and great smiles, Space Waves is a game that you can play online for free. Maintain a straight line while guiding a bright arrow through neon tunnels using a control that is simple and only requires one button. Every single run is quick, fair, and enjoyable thanks to the game's 33 colourful stages and immediate restarts. Is you prepared to surf the wave?

“The question of whether to create a psilocybin therapeutic access program is not about if, but how it will be implemented.” By Jessica Nielson, Minnesota Psychedelic Medicine Task Force via Minnesota Reformer The Minnesota Legislature in 2023 created the Psychedelic Medicine Task Force, which was charged with evaluating whether we should expand access to psychedelic medicines here to help address the rampant mental health crisis. The backdrop: Promising therapies like psilocybin-assisted treatments for depression, addiction and trauma are gaining traction towards approval by the Food and Drug Administration, and other states like Oregon and Colorado have already legalized therapeutic access. Wait, what are psychedelics you might ask? They are a class of drugs made illegal (Schedule I status) in 1970 with the birth of the Controlled Substances Act by the Nixon administration. In the 1950s through about 1970, they were gaining traction at psychiatric clinics, where they were being used to treat mental health conditions and alcohol abuse. At the same time, the hippies were also using them as part of the countercultural movement that was protesting the Vietnam War and supporting the Civil Rights Movement. The Controlled Substances Act effectively launched the War on Drugs and halted progress on promising research into the therapeutic potential of psychedelics—like so-called magic mushrooms aka psilocybin—for decades, and made all those who use them criminals. In recent years, however, there has been a surge of interest in psychedelic medicines for their potential to change the way the brain functions, potentially alleviating some of the most difficult-to-treat mental health conditions that are byproducts of neurological patterns that get stuck in a pathological cycle. Psychedelics are able to make the brain more capable of changing, a term called neuroplasticity, which has a lot of researchers and clinicians excited about their therapeutic applications for neurological and mental health disorders. Fast forward to 2026, when President Donald Trump signed an executive order to accelerate access to psychedelic medicines. It also included a section directing federal agencies to develop a framework for state-federal collaboration, which was a response to the surge of psychedelic-focused legislation we’ve seen around the country in recent years. All of this recent momentum made for a very productive legislative session on psychedelics. Several bills moved through the Legislature, though we came up short of our ultimate goal, which was to create a therapeutic access program with psilocybin mushrooms. We did manage to get passed a directive to the Office of Cannabis Management to implement a feasibility study and legislative report due January 15, 2027. The report will outline a framework to implement a therapeutic psilocybin program with patients who have undergone screening and have a qualifying health condition. Over the coming months, the Office of Cannabis Management will be working on their report about what the regulatory landscape will look like to develop and implement a state-regulated therapeutic psilocybin program. Thanks to the leaders who participated in the Psychedelic Medicine Task Force, Minnesota already has a 200-page guidebook for legal, regulatory, scientific, cultural and ethical considerations for integrating psychedelic medicines into our society. It’s the result of 14 months of work by 23 members, and it can also serve as a national resource to help all states develop policies and programs related to this important work. The point being: the Office of Cannabis Management does not have to start from scratch. It already has the report, the policy framework advanced by the House, testimony from patients, veterans, clinicians and families—and a clear signal that there is broad interest in getting this right. The question of whether to create a psilocybin therapeutic access program is not about if, but how it will be implemented. We demonstrated this session that there is broad bipartisan support at the local, state and federal levels. Many states are considering legislation to determine how their state will address integrating psychedelic medicines into their systems of care, and Minnesota has an opportunity to be a leader and pioneer in this effort. With so much promising research and support for psychedelic medicines, we should view what passed this session as a planning phase for action in 2027, for the Legislature to pass this access program and help Minnesotans heal from some of the most difficult-to-treat mental health conditions impacting so many of our friends and family. Jessica Nielson, PhD, is chair of the Minnesota Psychedelic Medicine Task Force. She’s an adjunct assistant professor, in the Department of Psychiatry and Behavioral Sciences, University of Minnesota. She’s also founder and president, Psychedelic Society of Minnesota. This piece was first published by Minnesota Reformer. Photo courtesy of Mark Groeneveld. The post Minnesota Is On The Cusp Of Making Psychedelic Medicine Available (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. slot 5000

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. ufa88s

Pretty good post. I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts. Any way I'll be subscribing to your feed and I hope you post again soon. Big thanks for the useful info. ombak700

“Our current presumption has the practical effect of stripping those who use marijuana…of their Fourth Amendment right against unreasonable search and seizure.” By Carolina Journal The newest member of the 4th US Circuit Court of Appeals used a North Carolina case Wednesday to discuss the potential legal impact of shifting attitudes about marijuana. Judge Nicole Berner offered her commentary in an eight-page concurring opinion in United States v. Carson. Then-President Joe Biden appointed Berner to the 4th Circuit in 2024. Appellate judges upheld Jermaine Derrick Carson Jr.’s conviction on a federal charge of firearm possession by a felon. The court rejected Carson’s arguments that evidence against him should have been suppressed. That included evidence resulting from Asheville police detective Steven Escobedo frisking Carson during a traffic stop. Berner supported most of the majority decision. Yet she dedicated much of her concurrence to the link between marijuana and law enforcement searches. “I agree with my colleagues that our precedent in United States v. Sakyi dictates the outcome of this case,” Berner wrote, citing a 1998 4th Circuit precedent. “Sakyi created a presumption that a police officer has reasonable suspicion to frisk a suspect for a weapon during a traffic stop when he reasonably suspects that there are illegal drugs in the car,” Berner explained. “Applying this binding precedent, we are left with no choice but to conclude that Escobedo frisking Carson for weapons did not violate Carson’s Fourth Amendment rights because Escobedo reasonably suspected that there was marijuana in the car.” “The Sakyi presumption rests on a simple premise: ‘where there are drugs, there are almost always guns,’” Berner wrote. “This premise—that an individual who is suspected of being in proximity to illicit drugs is likely carrying a gun—can no longer hold water in this era of widespread marijuana legalization.” “In the nearly thirty years since Sakyi was decided, the purported nexus between marijuana use and gun possession has become attenuated,” she added. “Indeed, the Government conceded as much at oral argument.” “The legal landscape around marijuana use, both medical and recreational, has shifted considerably both at the state and federal level,” Berner continued. “Forty-seven states and the District of Columbia now allow the use of marijuana for medical purposes. Twenty-four states, including a number within the Fourth Circuit itself, have legalized recreational marijuana use. Though federal law continues to criminalize marijuana, the federal government ‘has largely tolerated the production and sale of marijuana when done in accord with state law, and it has allowed a multi-billion-dollar marijuana business to develop.’” “Sakyi relies on an assumption that individuals using and dealing illicit drugs are likely to be carrying guns for protection while engaged in illegal drug transactions,” Berner argued. “Against the backdrop of changes in federal law and widespread state legalization, such safety concerns are now notably absent for many marijuana users. An individual in Maryland, for example, can walk into a dispensary and legally purchase marijuana with no need for the type of protection upon which Sakyi based its nexus analysis.” Berner highlighted the actions of Asheville police in Carson’s case. “The facts of this case demonstrate this unassailable attenuation between marijuana use and dangerousness,” the judge wrote. “The officers themselves repeatedly assured Carson and the other occupants of the car that they were ‘not the weed police.’ Indeed, even though marijuana remains unlawful in North Carolina, the Asheville Police Department no longer charges individuals who possess personal use amounts of marijuana. This approach follows the lead of the Department of Justice which directed federal prosecutors to forgo marijuana prosecutions over a decade ago.” Government prosecutors are now “in the ‘awkward’ position of suggesting that ‘millions of Americans who now regularly use marijuana are categorically and unusually dangerous,’” Berner wrote. “The Supreme Court’s recent decision in United States v. Hemani underscores the need to revisit our presumption. There, the Court held unconstitutional a statute criminalizing firearm possession as applied to occasional marijuana users.” “The Court explicitly rejected that a link between dangerousness and marijuana use could be sustained in view of the evolving legal and social landscape,” the concurrence continued. “Yet, under the law of our circuit, reasonable suspicion to frisk for weapons continues to be presumed anytime a police officer even so much as detects the smell of marijuana.” The 4th Circuit’s “approach stands in contrast to decisions from our sister circuits,” Berner argued. A single three-judge 4th Circuit panel could not change that approach. “Accordingly, we are bound by Sakyi, and I join my colleagues in their carefully reasoned opinion,” Berner wrote. “I write separately to underscore that our current presumption has the practical effect of stripping those who use marijuana, even in states where it has been legalized under state law, and even individuals who simply find themselves in near proximity to others using marijuana, of their Fourth Amendment right against unreasonable search and seizure.” “As laws and social mores regarding marijuana continue to evolve, this presumption may no longer survive constitutional scrutiny,” Berner added. This story was first published by Carolina Journal. Photo elements courtesy of rawpixel and Philip Steffan. The post Federal Judge Questions Link Between Marijuana And Guns, Citing ‘Widespread State Legalization’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Literally Document look at the software yesterday evening still I had produced a lot of emotions relating to this now I needed to read the software once as it is relatively well crafted. slot online

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. slot deposit 5k

You have a great sense of writing I must say. Your post has those facts which are not accessible from anywhere else. It’s my humble request to u please keep writing such remarkable articles mega.nz files

The website is looking bit flashy and it catches the visitors eyes. Design is pretty simple and a good user friendly interface. kokitoto

Nice blog and absolutely outstanding. You can do something much better but i still say this perfect.Keep trying for the best. 가상계좌 솔루션

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. bandar slot online

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value. Im glad to have found this post as its such an interesting one! I am always on the lookout for quality posts and articles so i suppose im lucky to have found this! I hope you will be adding more in the future... 가상계좌 솔루션

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. buastoto